These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 16234898)

  • 1. BNP in the diagnosis and risk stratification of heart failure.
    Moe GW
    Heart Fail Monit; 2005; 4(4):116-22. PubMed ID: 16234898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-type natriuretic peptide in heart failure.
    Moe GW
    Curr Opin Cardiol; 2006 May; 21(3):208-14. PubMed ID: 16601459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms.
    Januzzi JL; Chen-Tournoux AA; Moe G
    Am J Cardiol; 2008 Feb; 101(3A):29-38. PubMed ID: 18243855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health gains by using natriuretic peptides in diagnosis, prognosis and treatment.
    Richards M; Troughton R; Lainchbury J; Doughty R; Wright S
    Scand J Clin Lab Invest Suppl; 2005; 240():129-37. PubMed ID: 16112970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of N-terminal proB-type natriuretic peptide.
    Costello-Boerrigter LC; Burnett JC
    Nat Clin Pract Cardiovasc Med; 2005 Apr; 2(4):194-201. PubMed ID: 16265483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biomarkers in heart failure: BNP and NT-proBNP].
    Ho CC; Liu CC
    Hu Li Za Zhi; 2009 Oct; 56(5):16-22. PubMed ID: 19760573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-type natriuretic peptides: prognostic markers in stable coronary artery disease.
    Omland T
    Expert Rev Mol Diagn; 2008 Mar; 8(2):217-25. PubMed ID: 18366308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of B-type natriuretic peptide outside of the emergency department.
    Maeder MT; Mueller C; Pfisterer ME; Buser PT; Brunner-La Rocca HP
    Int J Cardiol; 2008 Jun; 127(1):5-16. PubMed ID: 18191484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.
    Lam CS; Burnett JC; Costello-Boerrigter L; Rodeheffer RJ; Redfield MM
    J Am Coll Cardiol; 2007 Mar; 49(11):1193-202. PubMed ID: 17367664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure.
    Omland T
    Crit Care Med; 2008 Jan; 36(1 Suppl):S17-27. PubMed ID: 18158473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.
    Omland T; Sabatine MS; Jablonski KA; Rice MM; Hsia J; Wergeland R; Landaas S; Rouleau JL; Domanski MJ; Hall C; Pfeffer MA; Braunwald E;
    J Am Coll Cardiol; 2007 Jul; 50(3):205-14. PubMed ID: 17631211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino-terminal pro-B-type natriuretic peptide testing for inpatient monitoring and treatment guidance of acute destabilized heart failure.
    Bettencourt P; Januzzi JL
    Am J Cardiol; 2008 Feb; 101(3A):67-71. PubMed ID: 18243862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NT-proBNP and BNP: biomarkers for heart failure management.
    Bettencourt P
    Eur J Heart Fail; 2004 Mar; 6(3):359-63. PubMed ID: 14987589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino-terminal pro-B-type natriuretic peptides and prognosis in chronic heart failure.
    Masson S; Latini R
    Am J Cardiol; 2008 Feb; 101(3A):56-60. PubMed ID: 18243860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The differential diagnosis of an elevated amino-terminal pro-B-type natriuretic peptide level.
    Baggish AL; van Kimmenade RR; Januzzi JL
    Am J Cardiol; 2008 Feb; 101(3A):43-8. PubMed ID: 18243858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results.
    Wu AH
    Am Heart J; 2006 Nov; 152(5):828-34. PubMed ID: 17070141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Type B natriuretic peptide (BNP) versus n-terminal type B natriuretic propeptide in the diagnosis of cardiac failure in the elderly over 75 population].
    El Mahmoud R; Alibay Y; Brun-Ney D; Boulard JC; Dubourg O; Puy H; Jondeau G
    Arch Mal Coeur Vaiss; 2006 Mar; 99(3):201-7. PubMed ID: 16618022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.